Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 13 of 13)As of 23-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
13-Nov-09Roth Capital Partners, Inc.James J. Tong PhD3Q Results Top Estimates, Again. Raise Estimates, Raise PT to $12.806$25  View Abstract
12-Nov-09Roth Capital Partners, Inc.Sean Jiang, James J. Tong PhDRaise 2010 Estimates Following an Upbeat 3Q09, Raise PT to $5.506$25  View Abstract
11-Nov-09Roth Capital Partners, Inc.Howard Zhou, James J. Tong PhDHypertension Curbed by Probiotics --- An Update on the Science of Probiotics4$10  View Abstract
11-Nov-09Roth Capital Partners, Inc.Sean Jiang, James J. Tong PhDCPHI: In Line Revenue, $0.05 Beat on EPS, Bolstered By $2.8MM Bad Debt Recovery6$25  View Abstract
10-Nov-09Roth Capital Partners, Inc.James J. Tong PhDAOB 3Q09 Preview4$10  View Abstract
10-Nov-09Roth Capital Partners, Inc.James J. Tong PhDLess Expeditious Sales Recovery for 3Q, Eyeing 2010 for Upside, Maintain Hold6$25  View Abstract
29-Oct-09Roth Capital Partners, Inc.James J. Tong PhDRaising Est's/PT On SCR Following Yanshen Vaccine Business Acquisition6$25  View Abstract
28-Oct-09Roth Capital Partners, Inc.James J. Tong PhDBulk Additive Updates, Model Revision Following Over-allotment Exercise6$25  View Abstract
23-Oct-09Roth Capital Partners, Inc.James J. Tong PhDCAO Takes Helm Following CFO Departure4$10  View Abstract
20-Oct-09Roth Capital Partners, Inc.James J. Tong PhDFundamentals Improvement Continues; Raising PT to $5; Maintain Buy Rating6$25  View Abstract
20-Oct-09Roth Capital Partners, Inc.James J. Tong PhDCancer Drug Development Collaboration with OSI Pharma4$10  View Abstract
14-Oct-09Roth Capital Partners, Inc.James J. Tong PhDProbiotic Supplements Reduce Flu-like Symptoms4$10  View Abstract
9-Oct-09Roth Capital Partners, Inc.James J. Tong PhDHealth Care Reform Update: Price Adjustment ~12% in 45% of Essential Drugs2$10  View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.